MedPath

Virazole

VIRAZOLE® (Ribavirin for Inhalation Solution, USP)

Approved
Approval ID

adf16e64-345f-469a-b987-3fbdd17e0ac2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 1, 2019

Manufacturers
FDA

Bausch Health US, LLC

DUNS: 831922468

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ribavirin

PRODUCT DETAILS

NDC Product Code0187-0007
Application NumberNDA018859
Marketing CategoryC73594
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 1, 2019
Generic NameRibavirin

INGREDIENTS (1)

RibavirinActive
Quantity: 6 g in 1 1
Code: 49717AWG6K
Classification: ACTIB

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 5/1/2019

PRESCRIBING INFORMATION

© Copyright 2025. All Rights Reserved by MedPath
Virazole - FDA Approval | MedPath